2025 EBOO G1 Device Buyer Guide

Buyer guide to the 2025 EBOO G1 Device — the compact prior-generation EBOO research machine. Specs, compatible EBOO filters, tubing, lines, and how to buy for laboratory research use.

Direct Answer

The 2025 EBOO G1 Device is the compact prior-generation EBOO research machine offered by EBOO Filters for controlled laboratory, training, and equipment-evaluation workflows. It is priced at $14,995 and pairs with the standard EBOO consumables catalog — EBOO filters, EBOO lines & tubing, and complete EBOO supply kits. See the 2025 EBOO G1 Device product page for current configuration details and order verification information.

This guide is G1-specific. If you are evaluating the current-generation platform instead, read the EBOO Machine Buyer Guide for Research Facilities covering the EBOO O3 Research Device 2026.

What the 2025 EBOO G1 Device Is

The 2025 EBOO G1 Device is a compact EBOO research machine designed for laboratories that need a smaller-footprint platform for controlled research workflows involving filtration, tubing, ozone/oxygen handling, and UV components. It sits in the EBOO Filters equipment catalog alongside the newer 2026 EBOO O3 Device, which is the current featured platform.

The G1 is not a medical device. EBOO Filters does not make therapy, treatment, detox, cure, disease, patient outcome, or clinical claims of any kind in connection with the 2025 EBOO G1 Device. It is supplied for laboratory and research use only.

Who the G1 Is For

The G1 is typically evaluated by:

  • Research groups that already run EBOO or EBO2 protocols and want a smaller, dedicated bench unit
  • Training environments and teaching labs where a compact platform is easier to place and instruct on
  • Facilities that need a secondary machine for equipment-evaluation runs, method development, or backup coverage
  • Buyers who want a lower entry-price research configuration than the current-generation O3 platform

If your protocol requires the O3's expanded ozone envelope, UVBI configuration, or the newest safety interlocks, the EBOO O3 Research Device 2026 is the better match. The G1 remains a strong choice where footprint, cost, and simplicity matter more than the widest possible parameter range.

G1 High-Level Reference Specifications

Specifications are configuration-dependent and confirmed during order verification, but the reference envelope for the 2025 EBOO G1 Device is:

| Parameter | Reference value | | --- | --- | | Voltage | 110–240 V configuration reference | | Pump speed | 1–99 RPM configuration reference | | Flowmeter | 0.1–1.5 LPM configuration reference | | Oxygen flow feed | 1–2 LPM configuration reference | | UV components | UVA/UVB/UVC configurations where applicable | | Size reference | Approximately 220 × 330 × 220 mm | | Weight reference | Approximately 7 kg | | Price | $14,995 |

Compare these to your protocol requirements. If a parameter you rely on sits outside the G1 envelope, contact us before ordering — the O3 platform may fit better.

Compatible Consumables

The 2025 EBOO G1 Device pairs with the standard EBOO consumables catalog. Most G1 buyers also order from:

  • EBOO supply kits — complete filters & lines 10-packs for ongoing research use and the lowest per-cycle cost
  • EBOO filters — replacement PES H200 filter membranes for single-use experimental cycles
  • EBOO lines & tubing — silicone tubing and full line sets, including EBO2-compatible options

Every consumable is single-use. Before your first G1 order, verify tubing inner diameter, connector standard, filter housing fit, and flow envelope against your existing protocol. If you are migrating from another EBOO configuration or from a legacy G1 unit, contact us first so we can review compatibility and recommend the right kit configuration.

How to Buy the 2025 EBOO G1 Device

The G1 uses the same authorize-first checkout workflow as the rest of the EBOO Filters catalog:

  1. Complete the order on the 2025 EBOO G1 Device product page and provide payment details.
  2. The payment method is authorized but not captured.
  3. Our team reviews the order, confirms configuration and package contents, and reaches out for verification.
  4. After verification, the authorized payment is captured and the device ships.

This gives procurement teams time to confirm the G1 is the right fit for their protocol before funds move. Institutional buyers with purchase orders, tax-exemption paperwork, or specific delivery windows should mention that at contact so we can align verification with your process.

G1 vs O3 — Choosing Between Them

Both the 2025 EBOO G1 Device and the EBOO O3 Research Device 2026 are research/laboratory use only, and both draw from the same consumables catalog. Where they differ:

  • Generation and footprint. The G1 is a compact prior-generation configuration at a fixed $14,995 price point. The O3 is the current-generation platform with a broader specification envelope and quote-based pricing.
  • Parameter range. The O3 supports the full 1–35 gamma envelope and a 5-lamp UVBI chamber; the G1 targets a narrower configuration suited to standard EBOO workflows.
  • Positioning. The G1 is a natural fit for training, secondary bench units, or budget-constrained facilities. The O3 is the recommended primary platform for facilities pushing the widest parameter range or running EBO2-mode work regularly.

For a full walk-through of the O3 platform and generic procurement checklists shared across both machines, see the EBOO Machine Buyer Guide for Research Facilities. This G1 guide focuses on the G1-specific decision points and does not repeat that content.

Buyer Checklist for the 2025 EBOO G1

  • [ ] Intended use confirmed as laboratory / research only
  • [ ] Protocol parameters fit within G1 reference envelope
  • [ ] Consumables forecast and standing reorder cadence planned
  • [ ] Bench footprint and 110–240 V power confirmed
  • [ ] Oxygen cylinder/regulator sourcing planned (typically separate)
  • [ ] Legacy-configuration compatibility reviewed with EBOO Filters if applicable
  • [ ] Verification-call window scheduled after order submission

Next Steps

Research/Laboratory Use Only. Not cleared or approved by the U.S. FDA for clinical, diagnostic, or therapeutic applications.